'Egfr mutation positive patients' diaporamas de présentation

Victor Cohen, MDCM, FRCPC Department of Oncology Segal Cancer Center

886 views • 62 slides

Thank you for downloading this update. Please feel free to use it for educational purposes.

Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial.

224 views • 8 slides

Tagrisso 80mg Tablets| Osimeritinib Uses & Side effects

Tagrisso 80mg tablet is for advanced non-small cell lung cancer with EGFR mutation positive patients, It is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment

79 views • 7 slides